An ongoing dialogue on HIV/AIDS, infectious diseases,
July 25th, 2012
AIDS Quilt, the Early 1990s, and Sadness
The early 1990s has potentially many associations — the break-up of the Soviet Union, the first Gulf War, the World Trade Center and Oklahoma City bombings, The Lion King, Forest Gump, The Fresh Prince of Bel-Air, “Smells Like Teen Spirit”, and the cancellation of the baseball season, to name a few. But we HIV/ID specialists will always […]
July 10th, 2012
Are ID Doctors the Worst Dressed Specialists?
Unusual exchange the other day with one of my (non-ID) colleagues. All dialogue reported verbatim: Non-ID guy: Hi Paul. Me: Hi Jon. [I’m expecting the next line to be: “Quick question: I’ve got a patient with a positive PPD and a history of BCG, etc.” Instead, it’s this bizarre comment:] Non-ID guy: You know, I would say that […]
July 5th, 2012
Home HIV Test Big News — But Why? And What Impact Will It Have?
The recent FDA approval of a home HIV antibody test (OraQuick In-Home HIV Test) was covered just about everywhere. It’s an oral swab test, takes 20-40 minutes, and will be available over-the-counter. How big a news story was it? Several hundred sources featured it on the day of the announcement, and the total count is now well over a thousand […]
July 1st, 2012
“HAART Era” Now Longer Than “Pre-HAART Era” — Can We Officially Retire “HAART”?
As I’ve shared before, I’m no fan of the term “HAART” and do everything I can to stop people from using it. (I’m a fun guy to have at parties.) I’m returning to this pet peeve of mine because I realized recently that we’ve passed a milestone of sorts: Period of no effective HIV treatment, 15 years (1981-1996) […]
June 29th, 2012
HIV Testing Roundup, and a Brief Rant
I’ve written so many times about HIV testing that a complete list of the headlines fills two full web pages. But since the last entry on the topic was more than a month ago, one might think I’ve lost interest in the topic. Never! Three items on the HIV Testing radar, two national, one local. First, for a classic […]
June 24th, 2012
ID Learning Unit — Choosing a Quinolone
We love quinolones on medical services, and it’s easy to understand why. Advantages: Ideal spectrum for several common infections, including community-acquired pneumonia, UTIs, and more complex infections when combined with other drugs Great oral absorption Few drug-drug interactions Once- or twice-daily dosing Generally well tolerated Reasonable cost But how do you choose between them? Below, in […]
June 20th, 2012
Abacavir Becomes the Latest Generic Antiretroviral Agent
Hot on the heels of generic nevirapine comes generic abacavir: On June 18, 2012, FDA granted approval for a generic formulation of abacavir tablets, 300 mg, manufactured by Mylan Pharmaceuticals, indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. FDA has determined that the generic formulation is bioequivalent and, therefore, therapeutically equivalent to the […]
June 17th, 2012
For Inpatients, HIV Medication Errors Common — Then Promptly Corrected
Several papers have shown that antiretrovirals may be incorrectly prescribed for hospitalized patients with HIV. How do they do at Johns Hopkins — the site of one of the best comprehensive HIV programs in the country (and perennial US News and World Report #1 Hospital in the Universe)? As described in a new CID paper, investigators reviewed ART […]
June 15th, 2012
ID Learning Unit — The D Test
I suppose it’s not surprising that we’d follow-up the Etest with the D test, though perhaps if I were being alphabetical, the order would have been reversed. The D test is important, because it screens for a form of clindamycin resistance in MRSA that might otherwise not be detected — the “inducible” kind, which can be […]
June 12th, 2012
ID Learning Unit — The Etest
Every year I attend on the general medical service, so it gives me a chance to work directly with the medical residents — and to brush up on my non-ID-related Internal Medicine. In exchange for what they teach me, each day on rounds I try to tell them about at least one ID-related thing that they […]